Erin Borger
Vorstandsvorsitzender bei ExThera Medical Corp.
Aktive Positionen von Erin Borger
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
ExThera Medical Corp.
 ExThera Medical Corp. Medical/Nursing ServicesHealth Services ExThera Medical Corp. develops medical devices that address unmet clinical needs in the treatment of bloodstream infections and pathogen-reduction in blood banking. The company develops Seraph Microbind Affinity Blood Filter (Seraph), which captures and removes normal and drug-resistant bacteria, viruses, toxins, and pro-inflammatory cytokines from human blood; and offers solution for use in a dialysis, such as extracorporeal circuit for treating existing bloodstream infections. The company was founded in 2007 and is headquartered in Martinez, CA. | Direktor/Vorstandsmitglied | - | - |
| Vorstandsvorsitzender | 15.11.2023 | - |
Karriereverlauf von Erin Borger
Ehemalige bekannte Positionen von Erin Borger
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| LONGEVERON INC. | Direktor/Vorstandsmitglied | 12.02.2021 | 09.06.2023 |
| Independent Dir/Board Member | 12.02.2021 | 09.06.2023 | |
| National Parkinson Foundation, Inc. | Direktor/Vorstandsmitglied | 12.01.2014 | - |
Ausbildung von Erin Borger
| Wofford College | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 5 |
Operativ
| Director/Board Member | 3 |
| Independent Dir/Board Member | 1 |
| Undergraduate Degree | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 2 |
| Health Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| LONGEVERON INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
| National Parkinson Foundation, Inc. | Health Technology |
ExThera Medical Corp.
ExThera Medical Corp. Medical/Nursing ServicesHealth Services ExThera Medical Corp. develops medical devices that address unmet clinical needs in the treatment of bloodstream infections and pathogen-reduction in blood banking. The company develops Seraph Microbind Affinity Blood Filter (Seraph), which captures and removes normal and drug-resistant bacteria, viruses, toxins, and pro-inflammatory cytokines from human blood; and offers solution for use in a dialysis, such as extracorporeal circuit for treating existing bloodstream infections. The company was founded in 2007 and is headquartered in Martinez, CA. | Health Services |
- Börse
- Insiders
- Erin Borger
- Erfahrung
